Insider · CIK 0001718094
Kevin Schuyler
Files at ADIL (ADIAL PHARMACEUTICALS, INC.), VEEE (Twin Vee PowerCats, Co.), FRZA (Forza X1, Inc.). First filing Mar 19, 2026, latest Mar 19, 2026.
In brief
Kevin Schuyler files SEC Form 4 as director at VEEE (Twin Vee PowerCats, Co.), and also at ADIL (ADIAL PHARMACEUTICALS, INC.), FRZA (Forza X1, Inc.). Since Mar 19, 2026, Kevin Schuyler has reported 1 open-market buy worth $10k and 0 open-market sells worth $0, the latest filed on Mar 19, 2026.
A track record needs three past buys with six months of prices behind them; Kevin Schuyler has 0, so none is measured yet.
The newest scored trade: bought $10k of VEEE on Mar 19, 2026, filed Mar 19, 2026, scored 33 (weak). In the last 12 months: 1 buy worth $10k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VEEE: Twin Vee PowerCats, Co.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | Twin Vee PowerCats, Co. | $10k 25,000 shares | +400% | - |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Common Stock | +9,185 | $0.00 | $0 | 9,213 | Apr 9, 2026 |
| Mar 19, 2026 | VEEE Twin Vee PowerCats, Co. | POpen-market purchase Common stock | +25,000 | $0.41 | $10k | 31,252 | Mar 19, 2026 |
| May 29, 2025 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +28,000 | $0.00 | $0 | 28,000 | Jun 2, 2025 |
| May 19, 2025 | VEEE Twin Vee PowerCats, Co. | AGrant or award Stock Option (Right to Buy)derivative | +3,000 | $0.00 | $0 | 3,000 | May 21, 2025 |
| Nov 26, 2024 | FRZA Forza X1, Inc. | DDisposition to issuer Common Stock | -100,000 | - | - | 0 | Nov 26, 2024 |
| Nov 26, 2024 | VEEE Twin Vee PowerCats, Co. | AGrant or award Common Stock | +61,166 | - | - | 73,530 | Nov 26, 2024 |
| Nov 26, 2024 | FRZA Forza X1, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,500 | - | - | 0 | Nov 26, 2024 |
| Nov 26, 2024 | VEEE Twin Vee PowerCats, Co. | AGrant or award Stock Option (Right to Buy)derivative | +3,364 | - | - | 3,364 | Nov 26, 2024 |
Questions about Kevin Schuyler
Answered from the filings on this page, as of the latest one.
Is Kevin Schuyler buying or selling?
In the last 12 months Kevin Schuyler reported 1 open-market buy worth $10k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $10k of VEEE on Mar 19, 2026. Grants, option exercises and tax withholding are not counted.
How did Kevin Schuyler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kevin Schuyler has 0.
Where does Kevin Schuyler file Form 4?
Kevin Schuyler has filed Form 4 at VEEE (Twin Vee PowerCats, Co.); ADIL (ADIAL PHARMACEUTICALS, INC.); FRZA (Forza X1, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.